Showing 1 - 10 of 718
Einführung in das Thema -- Aktuelle Patentausläufe und die an ihnen beteiligten Unternehmen -- Theoretische und empirische Grundlagen -- Der Produktlebenszyklus von Arzneimitteln -- Die Rolle von Patenten in der pharmazeutischen Industrie -- Auswirkungen von Patentausläufen in der...
Persistent link: https://www.econbiz.de/10013517082
This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...
Persistent link: https://www.econbiz.de/10013521260
an den Einkauf von Fertigarzneimitteln -- Verpackungsmitteleinkauf in der Pharmaindustrie -- Einkauf von CRO …. Zahlreiche Praxisbeispiele zeigen Besonderheiten: die komplexe Struktur des Arzneimittel- und Gesundheitsmarktes entlang der … Auswirkungen auf den Einkauf in der Pharmaindustrie, z. B. Digitalisierung, Telemedizin, personalisierte Medizin, integrierte …
Persistent link: https://www.econbiz.de/10014019602
process. The study explains why drug prices sometimes remain at elevated levels even after the drug’s patent protection has …
Persistent link: https://www.econbiz.de/10012396287
Persistent link: https://www.econbiz.de/10013518435
The book deals with collusion between firms on both sides of a market that is immune to deviations by coalitions. We study this issue using an infinitely countably repeated game with discounting of future single period payoffs. A strict strong perfect equilibrium is the main solution concept...
Persistent link: https://www.econbiz.de/10014015371
verschreibungspflichtiger Arzneimittel. Außerdem überprüft er anhand einer empirischen Untersuchung den Einfluss von über die Bereitstellung von …
Persistent link: https://www.econbiz.de/10013516566
60 supply chain specialists from production, distribution and retail of food and pharmaceuticals, drivers for resilience …
Persistent link: https://www.econbiz.de/10012402017
In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is...
Persistent link: https://www.econbiz.de/10012053872
, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving …
Persistent link: https://www.econbiz.de/10012397377